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• What is schistosomiasis? 



Hormones 
Hormones 

Schistosomiasis: facts and 
figures 
 
• Human schistosomes currently infect 
more than 200 million people in 76 
countries worldwide in the endemic 
areas of Africa, the Caribbean, Central 
America, South America, East Asia, and 
the Middle East.  
Hormones 

 • Is there a role for S. haematobium in 
bladder cancer? 
S. haematobium and bladder 
cancer 
 
• A causal association 
between the parasite 
and bladder cancer 
was postulated in 
1911 by Fergusson, 
but so far proof of 
this association has 
remained elusive. 
S. haematobium and bladder 
cancer 
 Squamous cell carcinoma of the urinary 
bladder has been associated with 
Schistosoma haematobium infection in many 
parts of Africa.  
 
 A parasite-tumor linkage is further suggested 
by the predominance of squamous cell (as 
opposed to transitional cell) morphology of 
bladder carcinomas seen in S. haematobium-
endemic areas. 
  
• What about host endocrine system? 
 
 
It has been shown that schistosomes synthesizes 
steroid hormones (Nirde et al, FEBS Letters, 1983). 
 
Schistosomes produce hormone-like signals 
(Mendonça et al, Parasitology Today, 2000).  
 
Existence of receptors able to bind the 
molecules of estradiol (Barrabes, Ann Parasitol Hum 
Comp, 1986; Mendonça et al, Parasitology Today, 2000). 
Schistosomiasis and host 
hormones 
 
 
Recent experimental evidence suggests that 
schistosomes can not only evade immune 
responses actively but also exploit the hormonal 
microenvironment within the host to favor their 
establishment, growth and reproduction (Escobedo 
et al, Trends in Parasitology, 2005). 
Schistosomiasis and host 
hormones 
Aims 
 
 A) To study the mechanisms underlying the 
association between S. haematobium and SCC 
of the bladder 
 B) To understand how host endocrine system 
can favor the establishment of schistosomes 
S. haematobium and bladder 
cancer 
Schistosoma haematobium immature worms 
induce granulomatous-like immune reaction and 
hepatic fibrosis similar to parasite eggs 
 
Methodological strategy 
Methodological strategy 
Schistosoma haematobium immature worms induce 
granulomatous-like immune reaction and hepatic 
fibrosis similar to parasite eggs 
Botelho et al. Virulence 2010 
S. haematobium total antigen increases 
the proliferation, decreases the apoptosis 
and induces invasion of epithelial cells in 
vitro 
 
Hormones 
Methodological Strategy 
S. haematobium 
total antigen (Sh) 
Chinese Hamster 
Ovary (CHO) cells 
Sh-treatment 48 h  
Methodological Strategy 
Methodological Strategy 
Proliferation  MTT assay 
Yellow MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, a tetrazole) is reduced to 
purple formazan in the mitochondria of living cells. 
Methodological Strategy 
DNA content  Flow cytometry 
Methodological Strategy 
Protein expression  Western blot 
The western blot is used to detect specific proteins in a given sample of tissue 
homogenate or extract. It uses gel electrophoresis to separate native or 
denatured proteins. The proteins are then transferred to a membrane where 
they are detected using antibodies specific to the target protein. 
S. haematobium total antigen increases the 
proliferation, decreases the apoptosis and 
induces invasion of epithelial cells in vitro 
Botelho et al. Int J Parsitol 2009 
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Methodological Strategy 
Apoptosis TUNEL (Terminal deoxynucleotidyl 
transferase dUTP nick end labeling) 
The assay relies on the presence of nicks in the DNA which can 
be identified by terminal deoxynucleotidyl transferase, an 
enzyme that will catalyze the addition of dUTPs that are 
secondarily labeled with a marker. It may also label cells that 
have suffered severe DNA damage. 
Methodological Strategy 
1. Cell suspension is placed in upper 
chamber and incubated for 24-72 
hours at 37 C.  
2.  Invasive cells pass through the 
membrane and cling to the bottom of 
the polycarbonate membrane that is 
tissue culture-treated to enhance 
cell attachment.  
3. Non-invading cells cannot pass 
through the membrane and stay in 
the upper chamber. 
Invasion  Boyden chamber 
S. haematobium total antigen increases the 
proliferation, decreases the apoptosis and 
induces invasion of epithelial cells in vitro 
Botelho et al. Int J Parsitol 2009 
 
S. haematobium total antigen induces 
tumorigenesis 
 
Methodological Strategy 
Control CHO cells  Sh-treated CHO cells  
No Tumour Tumour-Bearing Nude Mouse 
 
Chinese Hamster 
Ovary (CHO) cells 
Sh-treatment 48 hours Nude mice 
S. haematobium total antigen induces 
tumorigenesis 
Botelho et al. Int J Exp Path  2009 
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Schistosoma haematobium total antigen 
induces dysplasia and KRAS gene 
mutations in CD-1 mice normal urothelium 
Pathogenic pathways of rat and mice urinary bladder carcinogenesis.  
Methodological Strategy 
Transurethral 
Catheterization 
Urothelial 
Denudation 
Sh-treatment 
/PBS 
1 hour 
In situ fixation 
10% PPA 
20 weeks 
40 weeks 
Methodological Strategy 
Schistosoma haematobium total antigen induces 
dysplasia and KRAS gene mutations in CD-1 mice 
normal urothelium 
Botelho et al. Urol Oncol 2009 
Botelho et al. (Submitted) 
Schistosomiasis and host 
hormones 
Estradiol (E2) 
 
Shistosoma haematobium produces an 
estradiol-related molecule 
 
Shistosoma haematobium produces an 
estradiol-related molecule 
Botelho et al. Exp Parasitol 2009 
Antigenic 
preparations 
E2 (pg/ml) 
± SD 
S. 
haematobium 
14,84±0,14 
S. mansoni 12,63±0,27 
F. haepatica <10 
H2Od <10 
10 nM E2 1632,99±2,
55 
 
S. haematobium produces estrogenic molecules 
that are able to down-regulate ER alpha and ER 
beta and repress ER transcriptional activity 
 
Methodological Strategy 
 
Gene expression Real-Time PCR  
Methodological Strategy 
 
Estrogen 
Responsive Element  
(ERE) 
Transfection  pERE-Luc 
Methodological Strategy 
 
Mass spectrometry LC-ESI-MS 
S. haematobium produces estrogenic molecules 
that are able to down-regulate ER alpha and ER 
beta and repress ER transcriptional activity 
Botelho et al. Exp Parasitol 2010 
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S. haematobium produces estrogenic molecules 
that are able to down-regulate ER alpha and ER 
beta and repress ER transcriptional activity 
Botelho et al. Exp Parasitol 2010 
S. haematobium produces estrogenic molecules 
that are able to down-regulate ER alpha and ER 
beta and repress ER transcriptional activity 
Botelho et al. Exp Parasitol  2010 
Schistosomiasis, bladder cancer 
and host hormones 
Schistosoma haematobium total antigen down-
regulates ER alpha and ER beta in HCV29 normal 
urothelial cells and down-regulates ER expression 
in the bladders of CD1 mice 
Botelho et al. Oncol Rep  2011 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
F
o
ld
 i
n
c
re
a
s
e
  
Gene Expression  
ER alpha 
ER beta 
  
 
  
 
 
S. haematobium total antigen induced increased 
proliferation, decreased apoptosis, and induced migration 
and invasion of normal epithelial cells in culture. In addition, 
the parasite extract has also the potential to induce 
tumour development, assessed by the use of a nude mice 
xenograft model. 
 
According to our findings, S. haematobium total antigen in 
CD-1 mice normal bladders after intravesical instillation of 
the parasite antigen, induced alterations in the urothelium 
of these animals consistent with dysplasia and 
inflammation. In these animals, we also found that the 
parasite extract of S. haematobium has carcinogenic ability 
possibly through oncogenic mutation of KRAS gene. 
 
Conclusions 
S. haematobium and bladder cancer 
 
S. haematobium total antigen expresses estradiol-related 
molecules that down regulate Estrogen Receptor alpha and beta 
in estrogen responsive cells. These estrogens are also present 
in the sera of Schistosoma-infected individuals, and they have 
the ability to repress Estrogen Receptor transcriptional 
activity. 
 
The estrogenic molecules present in S. haematobium extracts 
could have a carcinogenic effect possibly through estrogen 
adduct-mediated pathway and could further explain the link 
between this parasite and squamous cell carcinoma of the 
bladder.. 
Conclusions 
S. haematobium and hormones 
 OVERALL 
 
  
 
Therefore, these results may 
open potential new strategies 
for cancer diagnosis by using 
these estrogens as biomarkers  
in schistosomiasis-associated 
bladder cancer. 
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Histopathological data in  the livers of 
infected animals.  
Histological findings of livers of 
infected animals. 
Histological findings of livers of 
infected animals. 
 
 
Schistosoma haematobium total antigen 
induces increased proliferation, 
migration and invasion, and decreases 
apoptosis of normal epithelial cells 
 
Monica Botelho, António Carlos Ferreira, 
Maria José Oliveira, José Carlos Machado 
and José Manuel Correia da Costa 
 
(International Journal for Parasitology, 2009) 
 
Methodological Strategy 
S. haematobium 
total antigen (Sh) 
Chinese Hamster 
Ovary (CHO) cells 
Sh-treatment 48 h  
Methodological Strategy 
 
S. haematobium total antigen induces 
alterations in the morphology of treated 
cells  
Morphological differences of CHO cells in culture. Control in the left 
panels and Sh-treated cells in right panels. 
Methodological Strategy 
Proliferation  MTS assay 
Yellow MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, a tetrazole) is reduced to 
purple formazan in the mitochondria of living cells.[1 
S. haematobium total antigen, but not S. 
mansoni total antigen, increased the 
proliferation of epithelial cells in vitro 
Cell Proliferation S. haematobium  vs. S. 
mansoni
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Methodological Strategy 
DNA content  Flow cytometry 
S. haematobium total antigen altered the 
cell cycle distribution decreasing G0/G1 
and increasing S- and G2/M-phase 
Groups 
Cell Cycle 
G0/G1 S G2/M 
Control 80.61  3.39 16.67  2.73 2.72  0.92 
Sh-treated 78.07 4.04 18.59  3.42 3.34  0.97 
Control Sh-treated 
Methodological Strategy 
Protein expression  Western blot 
The western blot is used to detect specific proteins in a given sample of tissue 
homogenate or extract. It uses gel electrophoresis to separate native or 
denatured proteins. The proteins are then transferred to a membrane where 
they are detected using antibodies specific to the target protein. 
Down-regulation of p27, a classic tumor 
supressor, in vitro, by S. haematobium total 
antigen 
 
p27 
beta-Actin 
 Control       Sh-treated 
Methodological Strategy 
Apoptosis TUNEL (Terminal deoxynucleotidyl 
transferase dUTP nick end labeling) 
The assay relies on the presence of nicks in the DNA which can 
be identified by terminal deoxynucleotidyl transferase, an 
enzyme that will catalyze the addition of dUTPs that are 
secondarily labeled with a marker. It may also label cells that 
have suffered severe DNA damage. 
S. haematobium total antigen decreased 
the apoptosis of epithelial cells in vitro  
Apoptosis
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Apoptosis of Sh treated cells analysed by TUNEL. 
The experiments were done in triplicate (*p<0,01; 
control vs. 50 microg/ml). 
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Up-regulation of the anti-apoptotic 
protein Bcl-2, in vitro, by S. 
haematobium total antigen 
 
M1 M1
Groups Bcl-2 
Control 50,11  1,39 
Sh-treated 52,99 2.04 
Histogram of CHO cells expressing BCL-2 by FACS analysis. Control left panel and Sh 
treated cells right panel. 
Induced migration of epithelial cells in 
vitro by S. haematobium total antigen 
0 h    24 h   48 h     72 h 
Control 
50 microg/ml 
Wound closure assay 
Methodological Strategy 
1. Cell suspension is placed in upper 
chamber and incubated for 24-72 
hours at 37 C.  
2.  Invasive cells pass through the 
membrane and cling to the bottom of 
the polycarbonate membrane that is 
tissue culture-treated to enhance 
cell attachment.  
3. Non-invading cells cannot pass 
through the membrane and stay in 
the upper chamber. 
Invasion  Boyden chamber 
Induced invasion of epithelial cells in vitro 
by S. haematobium total antigen 
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Tumorigenic effect of 
Schistosoma haematobium total 
antigen in normal mammalian cells 
 
 
 
 
Botelho M, Oliveira PA, Gomes J, 
Gartner F, Lopes C, Correia da Costa 
JM, Machado JC 
(Int. J. Exp. Path., 2009) 
Methodological Strategy 
S. haematobium 
total antigen (Sh) 
Methodological Strategy 
Control CHO cells  Sh-treated CHO cells  
No Tumour Tumour-Bearing Nude Mouse 
 
Chinese Hamster 
Ovary (CHO) cells 
Sh-treatment 48 hours Nude mice 
Sh allows the vigorous growth of CHO 
xenografts in nude mice 
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Immunohistochemistry and 
histochemical staining 
Immunohistochemistry Histochemistry 
Group Tumour Cytokeratin  Vimentin AgNORs 
1(Sh) Sarcoma - + 1,97 1,09 
1(Sh) Sarcoma - + 1,94 1,06 
1(Sh) Sarcoma - + 1,72 0,9 
1(Sh) Sarcoma - + 1,88 1,09 
1(Sh) Sarcoma - + 1,86 1,12 
2(Ctrl) - - - - 
2(Ctrl) - - - - 
2(Ctrl) - - - - 
Histological findings of the tumour 
mass produced by inoculation of CHO 
cells exposed to Sh 
A B 
C D 
 
 
Induced dysplasia and 
inflammation of Schistosoma 
haematobium total antigen on 
normal urothelium of CD-1 mice 
 
 
 
 
 
Botelho M , Oliveira PA, Lopes C, 
Correia da Costa JM and Machado 
JC 
(Urologic Oncology: Seminars and Original 
Investigations, 2009) 
Methodological Strategy 
S. haematobium 
total antigen (Sh) 
Methodological Strategy 
Transurethral 
Catheterization 
Urothelial 
Denudation 
Sh-treatment 
/PBS 
1 hour 
In situ fixation 
10% PPA 
20 weeks 
40 weeks 
Methodological Strategy 
Summary of the histopathological data 
in CD-1 mice urothelium exposed to Sh 
Group Umbrella cells Inflammation Dysplasia 
Sh (5/10) 50% (9/10) 90% (3/10) 30% 
Control (9/10) 80% (2/10) 20% (0/10) 0% 
Sh (0/10)  0% 10/10 (100%) 
(7/10) 70% 
P=0,001 
Control (10/10) 100%  3/10 (30%) (0/10) 0% 4
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Histological findings of CD-1 mice 
urothelium exposed to Sh 
 
 
Carcinogenic ability of S. 
haematobium through oncogenic 
mutation of KRAS gene 
 
 
 
 
Mónica Catarina Botelho, José Carlos 
Machado and José Manuel Correia da 
Costa 
(Virulence, 2010) 
KRAS exon 2 sequencing results 
 • Is there a role for S. haematobium in 
bladder cancer? 
 
 
 • Is there a role for S. haematobium in 
bladder cancer? 
 
• Yes! 
 • Is there a role for S. haematobium in 
bladder cancer? 
 
• Yes! 
Pathogenic pathways of rat and mice urinary bladder carcinogenesis.  
Take home message I 
• S. haematobium total antigen induced 
increased proliferation of normal epithelial 
cells in culture. 
• S. haematobium alters the cell cycle of 
treated cells as demonstrated by increased 
S-phase and down-regulation of the CDKI p27 
expression of normal epithelial cells in 
culture. 
• p27 causes cell cycle arrest in G1 phase and 
abrogating its function results in uninhibited 
cell proliferation and tumorigenesis. 
 
• S. haematobium dramatically decreased 
the apoptosis of epithelial cells by up-
regulating Bcl-2 protein. 
•  Treated cells with S. haematobium 
total antigen had increased migration 
than control cells.  
•  S. haematobium induced the invasion of 
treated cells 5 times more than control 
cells. 
Take home message II 
Take home message III 
• S. haematobium total antigen has the potential 
to induce tumour development, assessed by the 
use of a nude mice xenograft model. 
• S. haematobium total antigen in CD-1 mice 
normal bladders after intravesical 
administration of the parasite antigen, induced 
alterations in the urothelium of these animals 
consistent with dysplasia and inflammation .  
• The parasite extract of S. haematobium has 
carcinogenic ability possibly through oncogenic 
mutation of KRAS gene. 
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Specific Aim 
 
 To study schistosoma-associated SCC of the 
bladder through cancer pathways using in 
vitro and in vivo approaches. 
 
Ongoing work 
• Animal studies with experimental 
infections 
Pathogenic pathways of rat and mice urinary bladder carcinogenesis.  
S. haematobium and host 
hormones  
 
• Male hypogonadism is a well known consequence of 
schistosomiasis (Saad, J Egypt Soc Parasitol, 1999). 
• It has been shown that schistosomes synthesizes 
steroid hormones (Nirde et al, FEBS Letters, 1983). 
• Schistosomes produce hormone-like signals 
(Mendonça et al, Parasitology Today, 2000). 
• Existence of receptors able to bind the molecules of 
estradiol (Barrabes, Ann Parasitol Hum Comp, 1986; 
Mendonça et al, Parasitology Today, 2000). 
S. haematobium and host 
hormones 
 
• Recent experimental evidence suggests that 
schistosomes can not only evade immune 
responses actively but also exploit the 
hormonal microenvironment within the host to 
favor their establishment, growth and 
reproduction (Escobedo et al, Trends in 
Parasitology, 2005). 

Hormones 
ICI 182,780  

Hormones Botelho M et al. Journal 
of Parasitology (In 
Press) 
S. haematobium infected patients have 
increased serum levels of estradiol 
Sex 
Age   
(years) 
E2 Range Testosterone Range LH Range 
Female 4 62,8 0-22 <15,0 2-10 0,114 <2,5 
Male 12 30,8 0-25 77,5 5-500 1,79 0,2-8,0 
Male 14 79,8 0-25 363 5-500 1,89 0,2-8,0 
Male 17 45,7 0-25 724 >200 5,89 1,4-7,7 
Male 17 31,9 0-25 535 >200 7,65 1,4-7,7 
Male 20 68,3 <56,0 982 262-1593 2,87 1,4-7,7 
Hormones Botelho M et al. Journal 
of Parasitology (In 
Press) 
S. haematobium and S. mansoni express an 
estradiol analogue but not Fasciola 
hepatica 
Antigenic preparations E2 (pg/ml)  SD 
S. haematobium 14,84 0,14 
S. mansoni 12,63 0,27 
F. haepatica <10 
H2Od <10 
10 nM E2 1632,99 2,55 
Hormones 
S. haematobium total antigen decreases 
estradiol production of CHO cells in vitro  
Estradiol 
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Estradiol production in culture. The experiments were done in triplicate (p<0,01; control vs. 50 
microg/ml). 
ICI 182,780  Estradiol (E2) 

Hormones 
ICI 182,780  
Hormones 
S. haematobium total antigen is an 
antagonist of estradiol  
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Estradiol production in supernatant of treated cells. Data represent means SEM from 3 
independent experiments (* p<0,05 control vs. Sh). 
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Hormones 
S. haematobium total antigen down-regulates ER 
beta 
 
ER beta 
 
ER alpha 
 
beta-Actin 
Control        ICI           E2           ICI+E2        Sh          Sh+ICI     Sh+E2   Sh+ICI+E2 
RT-PCR for ER alpha and ER beta in CHO cells. 
Hormones 
Estrogen Responsive 
Element  (ERE) 
Hormones 
Inactivation of Estrogen Receptor signaling 
pathway by S. haematobium total antigen 
pERE-Luc transfection
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Role of Sh on inactivation of Estrogen Responsive Element (ERE) assessed by 
Luciferase Assay. Incubation with Sh resulted in a statistically significant 
decrease in luciferase activity compared to control (*, P <0.05).  
* 
Egg with miracidium 
Calcified egg 
Hormones 
Hormones 
Hormones 
Schistosomula 
  
Adult worms in: 
blood vessel 
around rectum 
(mansoni)  
bladder 
(haematobium)  
mesenteric 
veins and 
pulmonary 
arteries 
(japonicum)  
 
 
Egg production 
(10-30 per day) 
Cercaria (500 
per year per 
snail) 
  
  
Sporocysts 
(several per 
miracidium) 
  
  
  
 
 
 
 
Miracidium in 
water 
Hormones 
Hormones 
Hormones 
Hormones 
Hormones 
Hormones 
Hormones 
Hormones 
Hormones 
Hormones 
Hormones 
Hormones 
Hormones 
Hormones 
Hormones 


Hormones 
“Welcome to the fabulous world 
of parasites” 
Mónica Botelho 
 06/07/07 
 
Hormones 
 
 
 
• What is a parasite? 
Hormones 
• Parasitism, wherein one organism, 
usually physically smaller of the two 
(the parasite) benefits and the other 
(the host) is harmed.  
Hormones 
Parasitism is one version of symbiosis  
("living together"), a phenomenon in which  
two organisms which are phylogenetically  
unrelated co-exist over a prolonged period  
of time, usually the lifetime of one of the  
individuals.  
Hormones 
List of parasitic organisms  
• Helminths 
 
• Ascariasis (roundworms)  
• Cestoda (tapeworms) 
including: Taenia saginata 
(human beef tapeworm), 
Taenia solium (human pork 
tapeworm)    
• Enterobius vermicularias 
(pinworm)  
• Filariasis   
• Schistosomiasis or 
Bilharziosis 
• Protists (Protozoa) 
 
• Giardia lamblia (the most 
common intestinal protozoan 
in the United States)  
• Naegleria fowleri 
(facultative parasite causing 
amoebic meningitis)  
• Entamoeba histolytica 
(causes Amebiasis, common in 
developing countries)  
•  Trypanosoma (sleeping 
sickness or Chagas disease)  
•  Plasmodium (malaria) 
• Toxoplasma (toxoplasmosis) 
Hormones 
• Schistosoma haematobium 
Hormones 

Cancer pathways 
Tumorigenic effect of S. haematobium 
total antigen on normal epithelial cells 
Nude 
Mice 
Dia 15 
(mm3) 
Dia 20 
(mm3) 
Dia 30 
(mm3) 
Dia 90 
(mm3) 
Sh1 0 400 4416 Sacrif. 
Sh2 0,125 6375 Sacrif. - 
Sh3 0,125 1584 Sacrif. - 
Sh4 2808 7200 Sacrif. - 
Sh5 0 0 1870 Sacrif. 
C1 0 0 0 0,125 
C2 0 0 0 0 
C3 0 0 0 0 
Cancer pathways 
Tumorigenic effect of S. haematobium 
total antigen on normal epithelial cells 
 
 
• Histopathology 
– Inflammatory tumors 
– Lymphoid tissue 
 
Hormones 
Take home message II 
• S. haematobium infected patients have increased 
serum levels of estradiol, most likely Schistosoma 
derived. 
• S. haematobium total antigen expresses an analog of 
estradiol. 
• S. haematobium total antigen decreased estradiol 
levels in culture, acting as an estradiol antagonist. 
• S. haematobium total antigen down-regulates 
Estrogen Receptor beta. 
• In agreement with these data, we found that S. 
haematobium total antigen was able to inactivate ER 
transcription through the use of a pERE-Luc. 
 
 
Granulomatous-like immune reaction and 
hepatic fibrosis induced by Schistosoma 
haematobium immature worms  
 
Botelho MC, Oliveira PA, Vieira P, 
Delgado ML, Lourenço L, Lopes C, 
Machado JC and Correia da Costa JM 
(Virulence, ) 
 

